Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
platform
Biotech
Genetic medicines biotech halves team
The workforce reduction will affect 37 employees at the Boston biotech, according to Ensoma CEO Jim Burns, Ph.D.
Gabrielle Masson
Nov 20, 2025 10:15am
Biotech investors tip toe around the bear to familiar bets
Jan 16, 2024 6:00am
Tandem begins full U.S. rollout of diabetes management platform
Dec 13, 2023 10:14am
Fluidigm scores $250M infusion and a new CEO
Jan 24, 2022 11:33am
Harvard's Nabla Bio nabs $11M for AI-driven antibody design
Dec 7, 2021 9:34am
Automated lab platform Opentrons closes $200M series C
Sep 23, 2021 10:10am
